Recently, an original research article by the team of Chief Physician Zeng Xiaofeng, Director Li Mengtao, and Deputy Director Zhao Jiuliang of the Department of Rheumatology at PUMCH, in collaboration with Professor Du Guanhua's team from the In...
On October 16, 2025, the
rheumatology team led by Chief Physician Zhang Fengchun at PUMCH published the
phase 3 clinical trial results of telitacicept—a novel biological agent
independently developed in China—in the internationally authoritative The
New En...
Recently, Deputy Director He
Huaiwu and Director Long Yun from the Department of Critical Care Medicine at PUMCH,
in collaboration with Professor Zhao Zhanqi from the School of Biomedical
Engineering, Guangzhou Medical University, led the development of the...
Recently, the EEG and neurophysiology team from PUMCH's Department of Neurology, in collaboration with institutions including Beijing Tiantan Hospital, Capital Medical University and Children's Hospital Affiliated to Shandong University, published their multi-...
